arrow_back Back to App

Affordable Biologics: Patent Limits for Drug Manufacturers

This new law aims to make affordable biological drugs more accessible. It limits the number of patents that original drug manufacturers can use in lawsuits against companies introducing cheaper generic versions. This could lead to lower prices for important medications for citizens in the future.
Key points
Limits the number of patents that original drug manufacturers can assert in patent infringement lawsuits, aiming to accelerate the introduction of more affordable generic alternatives.
The changes apply to applications for biological product approval submitted after the law's enactment, meaning patient benefits will emerge over time.
article Official text account_balance Process page
Placed on Calendar
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1041
Sponsor: Sen. Cornyn, John [R-TX]
Process start date: 2025-03-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Affordable Prescriptions for Patients Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1041.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-03-13.

What are the main provisions?

Key points include:

  • Limits the number of patents that original drug manufacturers can assert in patent infringement lawsuits, aiming to accelerate the introduction of more affordable generic alternatives.
  • The changes apply to applications for biological product approval submitted after the law's enactment, meaning patient benefits will emerge over time.
What is the specific legal status?

The current status is Placed on Calendar.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cornyn, John [R-TX].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Courts and Law